282 related articles for article (PubMed ID: 10048980)
21. Induction of matrix metalloproteinases and collagenolysis in chick embryonic membranes before hatching.
Lei H; Furth EE; Kalluri R; Wakenell P; Kallen CB; Jeffrey JJ; Leboy PS; Strauss JF
Biol Reprod; 1999 Jan; 60(1):183-9. PubMed ID: 9858504
[TBL] [Abstract][Full Text] [Related]
22. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.
Wang M; Yoshida D; Liu S; Teramoto A
J Neurooncol; 2005 Mar; 72(1):1-9. PubMed ID: 15803368
[TBL] [Abstract][Full Text] [Related]
24. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
26. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
Redmond EM; Cahill PA; Hirsch M; Wang YN; Sitzmann JV; Okada SS
Thromb Haemost; 1999 Feb; 81(2):293-300. PubMed ID: 10064009
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro.
Chintala SK; Fueyo J; Gomez-Manzano C; Venkaiah B; Bjerkvig R; Yung WK; Sawaya R; Kyritsis AP; Rao JS
Oncogene; 1997 Oct; 15(17):2049-57. PubMed ID: 9366522
[TBL] [Abstract][Full Text] [Related]
28. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.
Koolwijk P; Sidenius N; Peters E; Sier CF; Hanemaaijer R; Blasi F; van Hinsbergh VW
Blood; 2001 May; 97(10):3123-31. PubMed ID: 11342439
[TBL] [Abstract][Full Text] [Related]
29. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
30. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
[TBL] [Abstract][Full Text] [Related]
31. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.
Monvoisin A; Bisson C; Si-Tayeb K; Balabaud C; Desmoulière A; Rosenbaum J
Int J Cancer; 2002 Jan; 97(2):157-62. PubMed ID: 11774258
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
33. The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase.
Zhang J; Sarkar S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2069-77. PubMed ID: 16033774
[TBL] [Abstract][Full Text] [Related]
34. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
35. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
Groft LL; Muzik H; Rewcastle NB; Johnston RN; Knäuper V; Lafleur MA; Forsyth PA; Edwards DR
Br J Cancer; 2001 Jul; 85(1):55-63. PubMed ID: 11437402
[TBL] [Abstract][Full Text] [Related]
36. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
[TBL] [Abstract][Full Text] [Related]
37. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells.
Hamasaki T; Hattori T; Kimura G; Nakazawa N
Urol Res; 1998; 26(6):371-6. PubMed ID: 9879815
[TBL] [Abstract][Full Text] [Related]
38. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
39. Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat.
Holst-Hansen C; Low JA; Stephens RW; Johnson MD; Carmeliet P; Frandsen TL; Brünner N; Dickson RB
Breast Cancer Res Treat; 2001 Aug; 68(3):225-37. PubMed ID: 11727959
[TBL] [Abstract][Full Text] [Related]
40. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
